Two clusters showed comparable overall tumor mutation burden (TMB) (Figure 3A), while interestingly, among 10 classical oncogenic pathways, only the TP53 pathway had a significantly higher mutation rate in cluster 1 (Figure 3B). The gene discussed is TP53; the disease is neoplasm.